Oksana Trotska
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by Amgen at 31.4% of the total. 2025 is the largest year on record at $711, 2.0 times the $350 reported in 2021.
Across 121 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$910
- AbbVie$456
- Novo Nordisk$278
- Pfizer$189
- Lilly USA, LLC$166
- Astellas Pharma US Inc$146
- plus $752 from 18 others
What the payments were for
- Food & beverage$2,896100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 31 | $910 |
| AbbVie | 14 | $456 |
| Novo Nordisk | 16 | $278 |
| Pfizer | 11 | $189 |
| Lilly USA, LLC | 10 | $166 |
| Astellas Pharma US Inc | 2 | $146 |
| Exact Sciences | 6 | $139 |
| Shield Therapeutics Inc | 6 | $109 |
| Phadia US Inc. | 2 | $84 |
| Boehringer Ingelheim | 4 | $65 |
| Abbott | 2 | $45 |
| Nestle Healthcare Nutrition Inc. | 2 | $40 |
| Seqirus USA Inc | 2 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $25 |
| GSK | 2 | $24 |
| Bayer | 1 | $24 |
| Redhill Biopharma Inc. | 1 | $22 |
| Visby Medical, Inc. | 1 | $22 |
| Aprecia Pharmaceuticals, LLC | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Medicomp Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,896 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ventolin HfaAlbuterol Sulfate | 22 | $1,232 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 13 | $968 |
| Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide | 12 | $907 |
| Losartan Potassium | 36 | $577 |
| Metformin Hcl | 32 | $383 |
| Metoprolol Succinate | 12 | $348 |
| Levothyroxine Sodium | 25 | $331 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $328 |
| Amlodipine Besylate | 27 | $326 |
| Atorvastatin Calcium | 31 | $288 |
| Omeprazole | 15 | $260 |
| Gabapentin | 20 | $208 |
| Rosuvastatin Calcium | 15 | $178 |
| Lisinopril | 24 | $176 |
| Fluticasone Propionate | 15 | $158 |
Paid to pharmacies, not to this prescriber.
Other family in Troy
- Daniela MaximTroy$112K
- Pamela JonesTroy$17K
- Mackenzie DifioreTroy$11K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.